eFFECTOR Therapeutics, Inc.
EFTR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $9 | $50 | $15 |
| Short-Term Investments | $3 | $18 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | -$0 | -$0 | $0 |
| Other Curr. Assets | $1 | $2 | $3 | $1 |
| Total Curr. Assets | $20 | $28 | $53 | $17 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $0 |
| Total NC Assets | $1 | $1 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21 | $29 | $54 | $17 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $0 |
| Short-Term Debt | $21 | $20 | $0 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $2 |
| Other Curr. Liab. | $3 | $3 | $3 | $0 |
| Total Curr. Liab. | $26 | $25 | $4 | $9 |
| LT Debt | $0 | $0 | $20 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $13 | $133 |
| Total NC Liab. | $1 | $0 | $33 | $140 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26 | $25 | $37 | $149 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $133 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$179 | -$144 | -$121 | -$137 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $347 | $147 | $138 | $4 |
| Total Equity | -$6 | $4 | $17 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21 | $29 | $54 | $17 |
| Net Debt | $6 | $12 | -$30 | -$2 |